Evidence map›Paper›PMID 40318182›Full record

Observational studyDiabetes, obesity & metabolism2025

Mortality risk following ischaemic and non-ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000-2021.

Kajal Panchal, Claire A Lawson, Sharmin Shabnam, Kamlesh Khunti, Francesco Zaccardi

Abstract readObservational Study
In one paragraph

Observational study in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kajal PanchalLeicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK.ORCID 0000-0003-4337-6094
Claire A LawsonDepartment of Cardiovascular Sciences, University of Leicester, Leicester, UK.
Sharmin ShabnamLeicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK.ORCID 0000-0002-2519-1240
Kamlesh KhuntiLeicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK.ORCID 0000-0003-2343-7099
Francesco ZaccardiLeicester Real World Evidence Unit, Leicester Diabetes Centre, University of Leicester, Leicester, UK.

Funding

National Institute for Health and Care Research, Applied Research Collaboration NIHR200171
6 · The paper itself

Abstract

aimsTo investigate the association between type 2 diabetes and all-cause mortality in people with ischaemic and non-ischaemic heart failure (HF).

methodsUsing the Clinical Practice Research Datalink primary care data, linked to hospital and mortality records, we identified newly diagnosed adults with type 2 diabetes between 2000 and 2021 and matched to up to four people without diabetes by sex, year of birth and general practice. We defined incident HF events as ischaemic if they followed an ischaemic heart disease event; otherwise, as non-ischaemic. We calculated sex-specific incidence rates and hazard ratios (HRs, adjusted for sociodemographic and clinical confounders) for all-cause mortality following HF diagnosis, comparing people with type 2 diabetes to those without diabetes.

resultsIn 73 344 people with HF (18 296 [24.9%] with ischaemic HF), 9584 and 31 800 deaths occurred in those with ischaemic and non-ischaemic HF, respectively. Age-standardised mortality rates following ischaemic HF were higher in people with type 2 diabetes (19.2 [95% CI: 18.1-20.3] and 20.4 [19.5-21.4] per 100 person-years in women and men, respectively) compared to those without diabetes (15.1 [14.4-15.8] and 16.5 [15.9-17.1], respectively). Corresponding rates in those with non-ischaemic HF were: 19.5 (19.0-20.1), 22.0 (21.4-22.6), 16.6 (16.2-17.0) and 19.4 (18.9-19.8). The HR for mortality was similar among HF types and between men and women: for ischaemic HF, 1.26 (1.17-1.36) in women and 1.23 (1.15-1.31) in men; for non-ischaemic HF, 1.24 (1.19-1.29) and 1.20 (1.15-1.25), respectively.

conclusionOur findings indicate broadly similar mortality rates in people with ischaemic and non-ischaemic HF, with higher rates in people with type 2 diabetes compared to those without diabetes in both women and men.

Indexed as

Diabetes Mellitus, Type 2Heart FailureMyocardial IschemiaAdultAgedAged, 80 and overEnglandFemaleHumansIncidenceMaleMiddle AgedRisk Factorscohort studydiabetes complicationsheart failurepopulation studyreal‐world evidencetype 2 diabetes

Identifiers

PMID40318182
PMCPMC12146457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.